Cardiocentro Ticino
Clinical trials sponsored by Cardiocentro Ticino, explained in plain language.
-
Heart stent patients: could a tailored blood thinner dose reduce risks?
Disease control Recruiting nowThis study looks for the safest and most effective dose of blood thinners (P2Y12 inhibitors) for people who have had a heart stent placed. About 355 participants will try different doses to find one that keeps blood clotting at a healthy level—not too high (which can cause clots)…
Phase: PHASE3 • Sponsor: Cardiocentro Ticino • Aim: Disease control
Last updated May 17, 2026 07:03 UTC
-
New blood thinner could make heart bypass safer during surgery
Disease control Recruiting nowThis study looks at whether giving a fast-acting blood thinner called cangrelor during a less invasive heart bypass surgery (MIDCAB) is safe and works well. About 30 adults with blocked heart arteries will get cangrelor through a vein during surgery, and their results will be com…
Sponsor: Cardiocentro Ticino • Aim: Disease control
Last updated May 17, 2026 06:50 UTC
-
AI reads ECGs to catch sneaky heart attacks before It's too late
Diagnosis Recruiting nowThis study tests whether an artificial intelligence (AI) program can help doctors detect a certain type of heart attack (occlusion myocardial infarction) earlier in people who come to the hospital with chest pain but whose standard ECG does not show clear signs. About 500 adults …
Phase: NA • Sponsor: Cardiocentro Ticino • Aim: Diagnosis
Last updated May 15, 2026 12:07 UTC
-
New heart ablation tool could cut radiation exposure for AF patients
Symptom relief Recruiting nowThis study tests a newer catheter for treating atrial fibrillation (an irregular heartbeat) that may eliminate the need for a pre-procedure CT scan, reducing radiation and costs. About 58 adults with AF who are candidates for ablation will be randomly assigned to the new or stand…
Phase: NA • Sponsor: Cardiocentro Ticino • Aim: Symptom relief
Last updated May 11, 2026 20:41 UTC